ASP1570

· Astellas Pharma Global Development, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASP1570, covering 2026-04-08 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors [Phase 1, Phase 2]

See pricing